The BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) funding program from the National Institutes of Health (NIH) supports Resource-Limited Institutions (RLIs) and Institutional Development Award (IDeA)-eligible institutions for scaled production and distribution of brain cell type-specific access reagents. The reagents to be distributed will first be developed in separately supported reagent design and development projects for brain cell type-specific access across vertebrate species in the BRAIN Initiative Armamentarium project. Applications are open to institutions in the USA.
The award provides research funding for up to 5 years.
Opportunity ID: RFA-MH-26-120
Letters of intent are due: May 15, 2027. Full applications are due: June 15, 2027.